<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en-US" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">global-journal-of-medical-research-f-diseases</journal-id>
<journal-title-group>
<journal-title>Global Journal of Medical Research - F: Diseases</journal-title>
</journal-title-group>
<issn publication-format="print">0975-5888</issn>
<issn publication-format="electronic">2249-4618</issn>
<publisher><publisher-name>Global Journals Publishing Group Incorporated</publisher-name></publisher>
<self-uri xlink:href="https://globaljournals.org/journal-seo-export/jats/61308.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">61308</article-id>
<title-group>
<article-title>Prevalence of Cervical Cancer in Developing Country: Pakistan</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Mukhtar</surname><given-names>Rubina</given-names></name><xref ref-type="aff" rid="aff1" />
</contrib>
</contrib-group>
<aff id="aff1">PAKISTAN</aff>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2015-05-15">
<day>15</day>
<month>05</month>
<year>2015</year>
</pub-date>
<volume>15</volume>
<issue>F3</issue>
<fpage>13</fpage>
<lpage>17</lpage>
<abstract><p>Objective: To find the prevalence of cervical carcinoma as seen at Multan Institute of Nuclear Medicine and Radiotherapy (MINAR), Pakistan. Methodology: This retrospective descriptive study was conducted at the Multan instituite or Nuclear Medicine and radiotherapy (MINAR) for a period of five years. The clinical records of all patients diagnosed with carcinoma of the cervix were reviewed with regard to sociodemographic and reproductive parameters. Frequency of Ca -cervix and stage of disease at the time of presentation were recorded. The data was collected on pre-designed Performa and analysed Statistically. Results: There were a total of 537 cases presented at MINAR during the study period. Presenting symptoms (PS) were irregular vaginal bleeding (IVB) in 78% patients including intermenstrual (IMB), post menopausal bleeding (PMB), epimenohrea and post coital bleeding (PCB). Vaginal discharge was PS in 29% while pelvic pain was PS in only 3% patients. Squamous cell carcinoma corresponds to 460 (86.5%), adeno carcinoma to 55 (10.8%) cases and Poorly differentiated/other rare Tumours 22 (4%). Only 102(19%) cases were in Stage Ib, while 247 (46%) were in Stages IIa and Stage IIb respectively, 118 (22%) cases were in Stages IIIa and Stage IIIb whilst 57 (10.8%) cases were in advanced stage (1V).</p></abstract>
<kwd-group kwd-group-type="author-generated">
<kwd>cervical cancer</kwd>
<kwd>prevalence</kwd>
<kwd>stage at diagnosis.</kwd>
</kwd-group>
<self-uri content-type="pdf" xlink:href="https://globaljournals.org/GJMR_Volume15/3-Prevalence-of-Cervical-Cancer.Pdf" />
<self-uri content-type="html" xlink:href="https://globaljournals.org/scholarly-articles/prevalence-of-cervical-cancer-in-developing-country-pakistan/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>Objective: To find the prevalence of cervical carcinoma as seen at Multan Institute of Nuclear Medicine and Radiotherapy (MINAR), Pakistan. Methodology: This retrospective descriptive study was conducted at the Multan instituite or Nuclear Medicine and radiotherapy (MINAR) for a period of five years. The clinical records of all patients diagnosed with carcinoma of the cervix were reviewed with regard to sociodemographic and reproductive parameters. Frequency of Ca -cervix and stage of disease at the time of presentation were recorded. The data was collected on pre-designed Performa and analysed Statistically. Results: There were a total of 537 cases presented at MINAR during the study period. Presenting symptoms (PS) were irregular vaginal bleeding (IVB) in 78% patients including intermenstrual (IMB), post menopausal bleeding (PMB), epimenohrea and post coital bleeding (PCB). Vaginal discharge was PS in 29% while pelvic pain was PS in only 3% patients. Squamous cell carcinoma corresponds to 460 (86.5%), adeno carcinoma to 55 (10.8%) cases and Poorly differentiated/other rare Tumours 22 (4%). Only 102(19%) cases were in Stage Ib, while 247 (46%) were in Stages IIa and Stage IIb respectively, 118 (22%) cases were in Stages IIIa and Stage IIIb whilst 57 (10.8%) cases were in advanced stage (1V).</p>
</sec>
</body>
</article>